enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers

Inclusion Criteria

Inclusion criteria for caregivers In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

1. English-speaking.
2. Ability to provide written or electronic informed consent to participate in the study.
3. Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
4. Age ≥ 18 years at the time of consent. Identify as an informal (unpaid) caregiver for a rural-dwelling adult with a stage II-IV solid tumor or any hematologic malignancy in active treatment (see eligibility criteria for patients).

Inclusion criteria for subjects with cancer In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

1. Their identified caregiver is enrolled in the study
2. English-speaking.
3. Ability to provide written or electronic informed consent to participate in the study.
4. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
5. Age ≥ 18 years at the time of consent. Have a diagnosis of stage II-IV solid tumor or any hematologic malignancy receiving active treatment s, not including hormonal therapy

7\. Live in a rural area according to the USDA's Rural/Urban Commuting Area (RUCA) score of \>4.

Exclusion Criteria

Exclusion criteria for caregivers

1. Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
2. Existence of another co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
3. Participation in the intervention development phase of this intervention.

Exclusion criteria for subjects with cancer

1. Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
2. Existence of another co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
3. Their caregiver does not enroll in the study or withdraws consent